Vaccine optimization for COVID-19: Who to vaccinate first?

Laura Matrajt1, Julia Eaton2, Tiffany Leung3

  • 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. laurama@fredhutch.org.

Science Advances
|February 4, 2021
PubMed

Insights

Vaccine allocation strategies are crucial for controlling COVID-19. Prioritizing older adults minimizes deaths with low-effectiveness vaccines, while younger groups are prioritized with high-effectiveness vaccines to reduce transmission.

Area of Science:

  • Epidemiology
  • Mathematical Modeling
  • Public Health

Background:

  • The COVID-19 pandemic necessitates effective control measures, with vaccines being a primary tool.
  • Anticipated vaccine shortages require strategic allocation to maximize public health benefits.
  • Mathematical modeling can inform optimal vaccine distribution strategies.

Purpose of the Study:

  • To determine optimal vaccine allocation strategies to mitigate the COVID-19 pandemic under various scenarios.
  • To evaluate the impact of vaccine effectiveness and coverage on allocation priorities.
  • To provide an evidence-based rationale for vaccine prioritization.

Main Methods:

  • An age-stratified mathematical model was developed to simulate COVID-19 transmission and outcomes.
  • Optimization algorithms were employed to identify vaccine allocation strategies.
  • Scenarios considered different vaccine effectiveness levels, vaccination coverages, and prioritization metrics (deaths, symptomatic infections, hospitalizations).

Main Results:

  • A vaccine with effectiveness of 50% or higher can substantially mitigate the pandemic if optimally allocated and widely administered.
  • For low vaccine effectiveness, prioritizing older, high-risk age groups is optimal for minimizing deaths, regardless of coverage.
  • For high vaccine effectiveness and high vaccination coverage, prioritizing younger, high-transmission age groups becomes optimal for minimizing deaths.

Conclusions:

  • Optimal vaccine allocation strategies are dynamic and depend on vaccine characteristics (effectiveness) and population behaviors (transmission patterns).
  • Prioritizing high-risk groups is crucial for low-effectiveness vaccines, while prioritizing high-transmission groups can be more effective for high-effectiveness vaccines.
  • This study provides a quantitative framework to support evidence-based decision-making for vaccine prioritization during pandemics.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
49.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
625
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
664
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
122
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
71
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
583